Drawing for JYSELECA

USPTO serial 88187139

JYSELECA

Reviewed by CopyMark Law Group

Reg. 6161152Status 700Renewal
Filing date
Status date
Registration date
Sep 29, 2020
Examiner
FATHY, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JYSELECA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jack Wessel

Jack Wessel Gilead Sciences, Inc.333 LAKESIDE DRIVEFOSTER CITY, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 24, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 24, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 29, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jul 21, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 21, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
May 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2020EX2GSOU EXTENSION 2 GRANTED—
May 15, 2020EXT2SOU EXTENSION 2 FILED—
May 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 25, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 25, 2019EXT1SOU EXTENSION 1 FILED—
Nov 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 9, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 14, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 2, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2019ALIEASSIGNED TO LIE—
Mar 20, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 14, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 14, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 14, 2019CNSLSUSPENSION LETTER WRITTEN—
Feb 13, 2019DOCKASSIGNED TO EXAMINER—
Nov 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance